Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
Apr 25 BLTE Belite Bio Announces $25 Million Registered Direct Offering
Apr 25 ASND Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
Apr 25 AMED Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
Apr 24 AMED Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
Apr 24 AMED Amedisys Non-GAAP EPS of $1.03 beats by $0.02, revenue of $571.41M beats by $2.16M
Apr 24 AMED Amedisys Reports First Quarter 2024 Financial Results
Apr 24 ALKS Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Apr 24 AMED Amedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Apr 24 ASND United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
Apr 24 ALKS Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1
Apr 23 ABT It’s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
Apr 23 AMED Here's Why Amedisys (AMED) is a Strong Value Stock
Apr 22 ALKS Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
Apr 22 BDX Top 5 U.S. Giants at Lucrative Valuations Amid April Turmoil
Apr 22 ABT Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario
Apr 20 ABT We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation
Apr 19 AMED DOJ case against UnitedHealth could take years to resolve, says BoA
Apr 19 BDX BDX or MMSI: Which Is the Better Value Stock Right Now?
Apr 19 ABT Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
Apr 19 ABT Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags